1 | | Primary | Los Altos | US | | Precision Therapeutics For Brain Health | N/A | Lauren Blake, Ph.D. | Data Scientist at Alto Neuroscience |
2 | | Primary Technologiepark-Zwijnaarde 94 | Ghent | BE | | Redefining Microbiome-Based Therapeutics | N/A | Sebastien Guery | Technology and Innovation Leader (a.i.) DuPont Nutrition and Biosciences |
3 | | Primary | New York City | US | | Translating Molecules Into Therapeutics | N/A | Alain Stricker-Krongrad | C.E.O. at Envol Biomedical |
4 | | Primary 4727 West 2nd Avenue | Vancouver | CA | | Developing Breakthrough Complement-Targeted Therapeutics | N/A | Douglas Bell | Immunological Researcher. Retired Head and Neck Surgeon. |
5 | | Primary 2 Eastbourne Terrace | London | GB | | Digital Therapeutics Reimagined | N/A | Jennifer Z. | Founder of DancingMind (Surge ‘19, Sequoia Capital) |
6 | | Primary 65 Westgate Road | Newcastle upon Tyne | GB | | Illuminating Therapeutics & Research Tools | N/A | Sam Whitehouse | CEO at LIGHTOX LIMITED |
7 | | Primary Hans-Bunte-Str. 19 | Freiburg | DE | | Unlocking Novel Therapeutics | N/A | andreas schaaf | managing director and chief strategy officer |
8 | | RENEURON PENCOED BUSINESS PARK | PENCOED | GB | | Pioneering Stem Cell Therapeutics | N/A | Nicholas Adams | VP Business Development & Alliance Management at RENEURON GROUP PLC |
9 | | RENEURON PENCOED BUSINESS PARK | PENCOED | GB | | Pioneering Stem Cell Therapeutics | N/A | olav hellebo | Chief Executive Officer |
10 | | Primary Gorbachev Street 002 E, VIT incubation cell, Vellore Institute of Technology | Vellore | IN | | Redefining Diagnostics and Therapeutics | N/A | Ravi Kiran Manapuram, PhD | Principal Investigator and Director at MedevPlus |
11 | | Primary 94/H 9th Cross, 13th Main, RMV Extension, Sadashivanagar | Bangalore | IN | | Telehealth Integrated Digital Therapeutics Platform | N/A | Kaif Salma | Senior Dietitian @7sugar.com |
12 | | Primary Avenida Tenente Valadim 17, 2F | Torres Vedras | PT | | Targeted Therapeutics | N/A | Raúl G. Saraiva, PhD | Biomedical Investment Manager at Portugal Ventures |
13 | | Primary Via Borgogna, 5 | Milan | IT | | First-In-Class Therapeutics For Autoimmune Disorders | N/A | Aurelia Ramunni | Executive Assistant at Enthera Pharmaceuticals |
14 | | Primary | Sydney | AU | | Advanced Therapeutics Within Everyone's Reach | N/A | Anthony Priyashantha Boteju | Head Of Marketing at Celltrion Healthcare Australia Pty Ltd |
15 | | Primary Wagramer Straße 19 | Vienna | AT | | Advancing Therapeutics. Improving Lives | N/A | Catia Lourenco | Receptionist |
16 | | Primary St. Alban-Anlage 44 | Basel | CH | | Selective Mode Antimicrobial Resistance Therapeutics | N/A | Frank Otto Gombert | CEO bei Selmod |
17 | | Primary Leonhardstraße 109 | Graz | AT | | Brain Implant Therapeutics | N/A | N/A | N/A |
18 | | Primary 26 Robinglade Dr | Toronto | CA | | The Therapeutics & Nutrition Cooperation | N/A | N/A | N/A |
19 | | Primary Spectrum Blvd | Tampa | US | | Tinnitus and Hearing Disorder Therapeutics | N/A | Luisa Scott, PhD | Cognosetta Founder | Innovator | Science Communicator | Expert in CNS disorders |
20 | | Primary 242 Digital-ro, Guro-gu | Seoul | KR | | Precision Oncology Therapeutics | N/A | song kyoung | Director |